This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Walgreens Never Said It Would Do an Inversion

Updated from 10:08 a.m. ET to include additional comments from Walgreens and analysts.

NEW YORK (TheStreet) -- Who's in control of Walgreens (WAG)?

The drugstore's decision Wednesday to remain headquartered in the suburbs of Chicago rather than move to Switzerland as it completes the acquisition of European pharmacy giant Alliance Boots, indicates that Walgreens' management may have retained its grip of the once family-run company amid investor scrutiny.

Shares of Walgreens were tanking, dropping nearly 14% to $59.50. News that the retailer will remain in Deerfield, Ill. hit Walgreens stock on Tuesday evening. A sharp cut to the company's guidance on Wednesday morning as it completes its Alliance Boots deal caused a further selloff. 

Must Read: Warren Buffett’s Berkshire Hathaway Has the Most Cash in America

Walgreens CEO Gregory Wasson initially dismissed the notion that the company could use the phase step of its acquisition of Alliance Boots to shift its tax headquarters abroad. Then, when hedge fund investors such as Jana Partners and Corvex Management pressured Walgreens to pursue such a move along with sweeping operational, financial and management changes, the company changed its tune.

Walgreens said in late April it was "evaluating" a tax inversion transaction and would update shareholders by the end of the summer. Some even speculated that Alliance Boots management, with the backing of investors, might quickly take the reins of Walgreens as both companies merged.

However, Wasson never said the company would actually go through with an inversion. On Wednesday morning, Wasson said that after analyzing the political, legal and consumer reaction to such a maneuver, the company decided to keep its tax headquarters in the U.S. That decision may have large ramifications on a growing trend among U.S. businesses to consider similar inversion transactions.

Spokesperson Michael Polzin said to complete an inversion Walgreens would have had to amend its Alliance Boots deal in a fundamental manner to avoid anti-abuse rules with the Internal Revenue Service. Instead, the company decided to accelerate its purchase of Alliance Boots without risking a legal limbo, CEO Wasson said on a call with analysts.

Perhaps, Walgreens' decision to remain in the U.S. signals that Wasson has a firm grip on Walgreens and the support of its board of directors, even if hedge fund investors have publicly said they would prefer the management team of Alliance Boots.

Wasson will remain CEO of the combined company, and Walgreens independent chairman James Skinner will be non-executive chairman the new company, which will be called Walgreens Boots Alliance.

Stefano Pessina, the head of Alliance Boots whom has tremendous support from hedge fund investors, will hold a role as executive chairman of Alliance Boots and executive vice chairman of the combined company. Pessina will report to Wasson and be tasked with strategy and M&A, in addition to chairing a strategy committee for the combined company.

Walgreens top brass, it appears, hold the reins of the combined Walgreens Boots Alliance. At the executive ranks, the story is the same.

Four of the nine-member member management team will be comprised of legacy Alliance Boots executives. However, Jefferies analysts note that Alliance Boots will have a prominent role in the combined company.

Alex Gourlay, a former Boots executive, will become president of Walgreens, while Ornella Barra, another Alliance Boots executive, will become CEO of global wholesale. Walgreens spokesperson Polzin said that new Alliance Boots executives may bring expertise in health and daily living to the combined management team, while Walgreens may bring new ideas Alliance Boots' retail pharmacy business.

Tim McLevish, an outside executive from Kraft Foods (KRFT) who was announced as Walgreens new CFO on Monday, will run the finances of the combined company.

"This combination is a true partnership, further evidenced by the composition of the future management team of Walgreens Boots Alliance," Pessina said in a Wednesday statement.

It is unclear whether Walgreens hedge fund shareholders who advocated an inversion, operational change and a significant influence of Alliance Boots management within the combined company will find Wednesday's moves to be sufficient.

Jana declined to comment. Corvex didn't return a call for comment.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CVS $101.45 0.95%
WAG $81.65 2.05%
AAPL $93.64 -0.11%
FB $118.57 0.84%
GOOG $698.21 0.75%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs